The product, Veti-Gel, was conceived and created by Joe Landolina, a freshman student at New York University in 2011, who discovered a substance that stops internal and external bleeding in a short period of time without the application of pressure. Mr. Landolina is now marketing the product to veterinarians through his company created around the innovation, Suneris.
Veti-Gel consists of a synthetic extracellular matrix, which stores proteins, sugars and other biological building blocks, which arrange themselves to take on the properties of whatever biological substance to which the gel is applied. The gel also promotes the production of fiber, which is vital to the clotting process.
If the gel gains approval for use in the military and trauma spaces, it will launch in the surgical market, where it could have applications as diverse as stopping bleeding during vascular surgery to saving lives in the case of severe liver trauma, according to Mr. Landolina.
More articles on accreditation:
Hydrocodone rules get tougher as DEA ups to Schedule II
Researchers testing surgical ‘black box’ to reduce errors
5 ideas for troubleshooting wait times in care
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.